Korea to put poison pill adoption on new policy agenda

Korea to put poison pill adoption on new policy agenda

South Korea will put the adoption of poison pills and dual-class shares on the new policy agenda at a meeting with business leaders this month, wher...

Samsung, SK Hynix asked to swallow tough pill over US CHIPS Act

Samsung, SK Hynix asked to swallow tough pill over US CHIPS Act

 WASHINGTON, D.C. – South Korean chipmakers on Tuesday expressed deep concerns about the detailed guidelines of the US CHIPS and Science ...

SK Chemicals launches uremia itching treatment tablet

SK Chemicals launches uremia itching treatment tablet

SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...

Korean bio firms look to pills, patches for people who fear needles

Korean bio firms look to pills, patches for people who fear needles

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

Ildong mulls seeking COVID-19 pill approval from Korea first

Ildong mulls seeking COVID-19 pill approval from Korea first

Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...

Korean drugmakers close to commercializing COVID-19 vaccine, pill

Korean drugmakers close to commercializing COVID-19 vaccine, pill

South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...

SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

Celltrion to co-develop pill-type autoimmune disease drug with UK startup

Celltrion to co-develop pill-type autoimmune disease drug with UK startup

Biosimilar maker Celltrion Inc. has agreed to develop a tablet-type treatment for autoimmune diseases jointly with the UK biotech startup Intract Phar...

Yes, it’s K-beauty: Buying interest for makeup brands runs high even before they're up for sale Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany